Matrix metalloproteinases in acute lung injury: Mediators of injury and drivers of repair

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 959-970

  Davey, A ^a   McAuley, D F ^b   O'Kane, C M ^b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Extracellular matrix; Inflammation; Matrix metalloproteinases; Repair

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BATIMASTAT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOXYCYCLINE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PENTOXIFYLLINE; PLACEBO; PRINOMASTAT; PROTEIN TYROSINE KINASE INHIBITOR; SALBUTAMOL; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BASEMENT MEMBRANE; CHRONIC LUNG DISEASE; DISEASE COURSE; EXTRACELLULAR MATRIX; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPEROXIA; HYPOXIA; KNOCKOUT MOUSE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG DYSPLASIA; LUNG INJURY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEOPLASM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; TISSUE REGENERATION; TISSUE REPAIR; VENTILATOR INDUCED LUNG INJURY; WOUND HEALING;

ACUTE LUNG INJURY; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; REGENERATION; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 79960166023     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00032111     Document Type: Review

References (74)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824. (Pubitemid 24082248)
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349. (Pubitemid 30408719)
3. Tsushima K, King LS, Aggarwal NR, et al. Acute lung injury review. Intern Med 2009; 48: 621-630.
4. Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011; 6: 147-163.
5. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005; 33: 319-327. (Pubitemid 41416281)
6. Empey DW. Diseases of the respiratory system. Introduction: structure and function of the lungs. Br Med J 1978; 1: 631-633. (Pubitemid 8337065)
7. Murray JF. The structure and function of the lung. Int J Tuberc Lung Dis 2010; 14: 391-396.
8. Dunsmore SE, Rannels DE. Extracellular matrix biology in the lung. Am J Physiol 1996; 270: L3-L27.
9. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 2007; 87: 69-98. (Pubitemid 46209991)
10. Lemaitre V, D'Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 2006; 78: 1-10. (Pubitemid 43726172)
11. O'Kane CM, Frank J, McAuley DF. Matrix metalloproteinases: a potential role in the pathogenesis of ARDS, In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. 1st Edn. Heidelberg, Springer, 2004; pp. 287-300.
12. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13: 534-540. (Pubitemid 32817010)
13. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14: 2123-2133.
14. Manicone AM, McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19: 34-41. (Pubitemid 350235986)
15. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-629. (Pubitemid 39025047)
16. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007; 8: 221-233.
17. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004; 16: 558-564. (Pubitemid 39201241)
18. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006; 61: 259-266.
19. Oikonomidi S, Kostikas K, Tsilioni I, et al. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr Med Chem 2009; 16: 1214-1228.
20. O'Kane CM, McKeown SW, Perkins GD, et al. Salbutamol upregulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009; 37: 2242-2249.
21. Gushima Y, Ichikado K, Suga M, et al. Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury. Eur Respir J 2001; 18: 827-837. (Pubitemid 33076926)
22. Cederqvist K, Janer J, Tervahartiala T, et al. Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat. Pediatr Res 2006; 60: 395-400. (Pubitemid 44427589)
23. Kim JY, Choeng HC, Ahn C, et al. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis. Yonsei Med J 2009; 50: 68-77.
24. Eichler W, Bechtel JF, Schumacher J, et al. A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model. Perfusion 2003; 18: 107-113. (Pubitemid 36850194)
25. Hirsh M, Carmel J, Kaplan V, et al. Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol 2004; 85: 147-157. (Pubitemid 39037023)
26. Delclaux C, d'Ortho MP, Delacourt C, et al. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol 1997; 272: L442-L451. (Pubitemid 27147382)
27. Pugin J, Verghese G, Widmer MC, et al. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999; 27: 304-312. (Pubitemid 29113539)
28. Lanchou J, Corbel M, Tanguy M, et al. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003; 31: 536-542. (Pubitemid 36232952)
29. Fligiel SE, Standiford T, Fligiel HM, et al. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol 2006; 37: 422-430.
30. Shyamsundar M, McKeown ST, O'Kane CM, et al. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009; 179: 1107-1114.
31. Sweet DG, McMahon KJ, Curley AE, et al. Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2001; 84: F168-F171. (Pubitemid 32411254)
32. Cederqvist K, Sorsa T, Tervahartiala T, et al. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001; 108: 686-692. (Pubitemid 32786599)
33. Sweet DG, Curley AE, Chesshyre E, et al. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr 2004; 93: 791-796. (Pubitemid 38736814)
34. Kong MY, Gaggar A, Li Y, et al. Matrix metalloproteinase activity in paediatric acute lung injury. Int J Med Sci 2009; 6: 9-17.
35. Griffin MO, Fricovsky E, Ceballos G, et al. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 2010; 299: C539-C548.
36. Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm Des 2007; 13: 333-346. (Pubitemid 46085282)
37. Kim JH, Suk MH, Yoon DW, et al. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L580-L587.
38. Doroszko A, Hurst TS, Polewicz D, et al. Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci 2010; 8: 3.
39. Carney DE, McCann UG, Schiller HJ, et al. Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res 2001; 99: 245-252. (Pubitemid 32703443)
40. Steinberg J, Halter J, Schiller HJ, et al. Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 2003; 111: 185-195. (Pubitemid 36808908)
41. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 1999; 100: 400-406. (Pubitemid 29362411)
42. Sochor M, Richter S, Schmidt A, et al. Inhibition of matrix metalloproteinase-9 with doxycycline reduces pancreatitis-associated lung injury. Digestion 2009; 80: 65-73.
43. Foda HD, Rollo EE, Drews M, et al. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340). Am J Respir Cell Mol Biol 2001; 25: 717-724. (Pubitemid 33124688)
44. Muhs BE, Patel S, Yee H, et al. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis. J Surg Res 2003; 109: 110-117. (Pubitemid 36315737)
45. Keck T, Balcom JH 4th, Fernandez-del Castillo C, et al. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002; 122: 188-201. (Pubitemid 34049207)
46. Mulligan MS, Desrochers PE, Chinnaiyan AM, et al. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2. Proc Natl Acad Sci USA 1993; 90: 11523-11527. (Pubitemid 24008671)
47. Gipson TS, Bless NM, Shanley TP, et al. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol 1999; 162: 3653-3662. (Pubitemid 29313621)
48. Coimbra R, Melbostad H, Loomis W, et al. LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-κB, and ICAM-1 expression. J Trauma 2006; 60: 115-125.
49. Kang JL, Lee HW, Lee HS, et al. Genistein prevents nuclear factor-κB activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med 2001; 164: 2206-2212. (Pubitemid 34032937)
50. Deree J, Martins JO, Leedom A, et al. Hypertonic saline and pentoxifylline reduces hemorrhagic shock resuscitation-induced pulmonary inflammation through attenuation of neutrophil degranulation and proinflammatory mediator synthesis. J Trauma 2007; 62: 104-111. (Pubitemid 46102839)
51. Chetty A, Cao GJ, Severgnini M, et al. Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am J Physiol Lung Cell Mol Physiol 2008; 295: L584-L592.
52. Warner RL, Beltran L, Younkin EM, et al. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol 2001; 24: 537-544. (Pubitemid 32442760)
53. Lukkarinen H, Hogmalm A, Lappalainen U, et al. Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2009; 41: 59-68.
54. Albaiceta GM, Gutierrez-Fernandez A, Parra D, et al. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 294: L535-L543. (Pubitemid 351468853)
55. Nerusu KC, Warner RL, Bhagavathula N, et al. Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp Mol Pathol 2007; 83: 169-176. (Pubitemid 47320658)
56. Li Q, Park PW, Wilson CL, et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002; 111: 635-646. (Pubitemid 35441246)
57. Kim KH, Burkhart K, Chen P, et al. Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol 2005; 33: 271-279. (Pubitemid 41254294)
58. Owen CA, Hu Z, Lopez-Otin C, et al. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 2004; 172: 7791-7803. (Pubitemid 38747647)
59. Quintero PA, Knolle MD, Cala LF, et al. Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1a to reduce acute lung inflammation and injury in mice. J Immunol 2010; 184: 1575-1588.
60. Albaiceta GM, Gutierrez-Fernández A, García-Prieto E, et al. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. Am J Respir Cell Mol Biol 2010; 43: 555-563.
61. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010; 298: L715-L731.
62. Rocco PR, Dos Santos C, Pelosi P. Lung parenchyma remodeling in acute respiratory distress syndrome. Minerva Anestesiol 2009; 75: 730-740.
63. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 2004; 113: 148-157.
64. Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008; 34: 619-630. (Pubitemid 351660085)
65. Rocco PR, Negri EM, Kurtz PM, et al. Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am J Respir Crit Care Med 2001; 164: 1067-1071. (Pubitemid 32971660)
66. Santos FB, Nagato LK, Boechem NM, et al. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 2006; 100: 98-106. (Pubitemid 43671095)
67. Negri EM, Hoelz C, Barbas CS, et al. Acute remodeling of parenchyma in pulmonary and extrapulmonary ARDS. An autopsy study of collagen-elastic system fibers. Pathol Res Pract 2002; 198: 355-361. (Pubitemid 34679105)
68. Marshall RP, Bellingan G, Webb S, et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162: 1783-1788.
69. Demoule A, Decailliot F, Jonson B, et al. Relationship between pressure-volume curve and markers for collagen turn-over in early acute respiratory distress syndrome. Intensive Care Med 2006; 32: 413-420. (Pubitemid 43289650)
70. Chao MC, Garcia CS, De Oliveira MB, et al. Degree of endothelium injury promotes fibroelastogenesis in experimental acute lung injury. Respir Physiol Neurobiol 2010; 173: 179-188.
71. McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003; 162: 1831-1843. (Pubitemid 36613042)
72. 1 integrin activation. PLoS One 2009; 4: e6565.
73. Chen P, McGuire JK, Hackman RC, et al. Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol 2008; 172: 1256-1270. (Pubitemid 351671539)
74. Buckley S, Driscoll B, Shi W, et al. Migration and gelatinases in cultured fetal, adult, and hyperoxic alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2001; 281: L427-L434.